STK vs. ABBV
STK (Columbia Seligman Premium Technology Growth Closed Fund) is Technology Equities fund actively managed by Aberdeen, while ABBV (AbbVie Inc.) is a stock. Over the past 10 years, STK returned 23.66%/yr vs 19.10%/yr for ABBV. At a 0.23 correlation, their price movements are largely independent.
Performance
STK vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, STK achieves a 44.26% return, which is significantly higher than ABBV's 1.30% return. Over the past 10 years, STK has outperformed ABBV with an annualized return of 23.66%, while ABBV has yielded a comparatively lower 19.10% annualized return.
STK
- 1D
- 2.32%
- 1M
- 4.91%
- YTD
- 44.26%
- 6M
- 47.42%
- 1Y
- 90.64%
- 3Y*
- 30.83%
- 5Y*
- 19.37%
- 10Y*
- 23.66%
ABBV
- 1D
- 1.32%
- 1M
- 8.24%
- YTD
- 1.30%
- 6M
- 3.65%
- 1Y
- 23.06%
- 3Y*
- 22.39%
- 5Y*
- 18.94%
- 10Y*
- 19.10%
STK vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
STK Columbia Seligman Premium Technology Growth Closed Fund | 44.26% | 24.85% | 17.74% | 46.60% | -30.36% | 48.63% | 25.39% | 52.73% | -14.91% | 33.52% |
ABBV AbbVie Inc. | 1.30% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between STK and ABBV is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.00 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.23 |
The correlation between STK and ABBV shifts across timeframes, from -0.05 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
STK vs. ABBV — Risk / Return Rank
STK
ABBV
STK vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Columbia Seligman Premium Technology Growth Closed Fund (STK) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| STK | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.52 | ||
| Sortino ratioReturn per unit of downside risk | +2.46 | ||
| Omega ratioGain probability vs. loss probability | 1.57 | 1.18 | +0.39 |
| Calmar ratioReturn relative to maximum drawdown | 5.57 | 1.29 | +4.28 |
| Martin ratioReturn relative to average drawdown | 24.83 | 2.88 | +21.95 |
Loading charts...
Drawdowns
STK vs. ABBV - Drawdown Comparison
The maximum STK drawdown since its inception was -41.74%, smaller than the maximum ABBV drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for STK and ABBV.
Loading charts...
Drawdown Indicators
| STK | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -41.74% | -45.09% | +3.35% |
Max Drawdown (1Y)Largest decline over 1 year | -16.05% | -17.32% | +1.27% |
Max Drawdown (3Y)Largest decline over 3 years | -26.59% | -20.74% | -5.85% |
Max Drawdown (5Y)Largest decline over 5 years | -36.27% | -21.92% | -14.35% |
Max Drawdown (10Y)Largest decline over 10 years | -41.74% | -45.09% | +3.35% |
Current DrawdownCurrent decline from peak | -9.90% | -4.60% | -5.30% |
Average DrawdownAverage peak-to-trough decline | -7.41% | -10.71% | +3.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.60% | 7.75% | -4.15% |
Volatility
STK vs. ABBV - Volatility Comparison
Columbia Seligman Premium Technology Growth Closed Fund (STK) has a higher volatility of 15.03% compared to AbbVie Inc. (ABBV) at 6.10%. This indicates that STK's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| STK | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.03% | 6.10% | +8.93% |
Volatility (6M)Calculated over the trailing 6-month period | 22.75% | 17.85% | +4.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.01% | 24.31% | +1.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.66% | 22.89% | +2.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.40% | 25.73% | +0.67% |
Dividends
STK vs. ABBV - Dividend Comparison
STK's dividend yield for the trailing twelve months is around 5.23%, more than ABBV's 2.96% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.96% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
STK Columbia Seligman Premium Technology Growth Closed Fund | 5.23% | 7.38% | 16.02% | 6.70% | 12.62% | 8.48% | 6.79% | 7.86% | 14.88% | 11.82% | 9.87% | 10.32% |
Frequently Asked Questions
STK and ABBV have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
STK has higher volatility (15.03%) compared to ABBV (6.10%). In terms of maximum drawdown, STK dropped -41.74% vs ABBV's -45.09%.
STK currently has the higher Sharpe Ratio (3.44 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for STK and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer